(2021). Immune-globulin/rituximab: Lack of efficacy: case report. Reactions Weekly.
Chicago Style Citation"Immune-globulin/rituximab: Lack of Efficacy: Case Report." Reactions Weekly 2021.
Cita MLA"Immune-globulin/rituximab: Lack of Efficacy: Case Report." Reactions Weekly 2021.
Atenció: Aquestes cites poden no estar 100% correctes.